Augmentin/Augmentin ES

Augmentin/Augmentin ES Use In Pregnancy & Lactation

amoxicillin + clavulanic acid




Full Prescribing Info
Use In Pregnancy & Lactation
Use in Pregnancy: Reproduction studies in animals (mice and rats at doses up to 10 times the human dose) with orally and parenterally administered Co-amoxiclav (Augmentin) have shown no teratogenic effects. In a single study in women with preterm, premature rupture of the foetal membrane (pPROM), it was reported that prophylactic treatment with Co-amoxiclav (Augmentin) may be associated with an increased risk of necrotising enterocolitis in neonates. As with all medicines, use should be avoided in pregnancy, unless considered essential by the physician.
Use in Lactation: Co-amoxiclav (Augmentin) may be administered during the period of lactation. With the exception of the risk of sensitisation, associated with the excretion of trace quantities in breast milk, there are no known detrimental effects for the breast-fed infant.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in